Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN).
Lupia T, Corcione S, Shbaklo N, Montrucchio G, De Benedetto I, Fornari V, Bosio R, Rizzello B, Mornese Pinna S, Brazzi L, De Rosa FG. Lupia T, et al. Among authors: mornese pinna s. J Funct Biomater. 2022 Oct 3;13(4):174. doi: 10.3390/jfb13040174. J Funct Biomater. 2022. PMID: 36278643 Free PMC article.
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.
Cusato J, Boglione L, De Nicolò A, Favata F, Ariaudo A, Mornese Pinna S, Guido F, Avataneo V, Cantù M, Carcieri C, Cariti G, Di Perri G, D'Avolio A. Cusato J, et al. Among authors: mornese pinna s. Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22. Cancer Chemother Pharmacol. 2018. PMID: 29356898
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients.
Cusato J, De Nicolò A, Boglione L, Favata F, Ariaudo A, Mornese Pinna S, Carcieri C, Guido F, Avataneo V, Cariti G, Di Perri G, D'Avolio A. Cusato J, et al. Among authors: mornese pinna s. Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13. Infect Genet Evol. 2018. PMID: 29452294
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship.
Corcione S, Lupia T, Maraolo AE, Mornese Pinna S, Gentile I, De Rosa FG. Corcione S, et al. Among authors: mornese pinna s. Curr Opin Infect Dis. 2019 Dec;32(6):663-673. doi: 10.1097/QCO.0000000000000598. Curr Opin Infect Dis. 2019. PMID: 31599774 Review.
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.
Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. Lupia T, et al. Among authors: mornese pinna s. J Glob Antimicrob Resist. 2020 Jun;21:22-27. doi: 10.1016/j.jgar.2020.02.021. Epub 2020 Mar 7. J Glob Antimicrob Resist. 2020. PMID: 32156648 Free PMC article. Review.
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia.
Corcione S, De Nicolò A, Montrucchio G, Scabini S, Avataneo V, Bonetto C, Mornese Pinna S, Cusato J, Canta F, Urbino R, Di Perri G, Brazzi L, De Rosa FG, D'Avolio A. Corcione S, et al. Among authors: mornese pinna s. Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4. Br J Clin Pharmacol. 2021. PMID: 33990984 Free PMC article.
36 results